This inventor holds 1 USPTO granted patent. Top assignee: New England Medical Center Hospitals. Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Ana Maria Cevallos: Innovator in Host-Parasite Interactions
Introduction
Ana Maria Cevallos is a notable inventor based in Coyoacan, Mexico. He has made significant contributions to the field of biotechnology, particularly in understanding host-parasite interactions. His work has implications for diagnostics and therapeutic methods.
Latest Patents
Cevallos holds a patent for his invention titled "GP40 and uses thereof." This patent relates to a gene encoding a novel protein, gp40. The gp40 polypeptides play a crucial role in mediating host-parasite interactions. The patent describes isolated and antisense nucleic acid molecules, recombinant expression vectors, and host cells. Additionally, it provides diagnostic, screening, and therapeutic methods utilizing the compositions of the invention.
Career Highlights
Ana Maria Cevallos is affiliated with New England Medical Center Hospitals, Inc. His work there has allowed him to explore innovative solutions in the medical field. He has a strong focus on research that bridges the gap between basic science and clinical applications.
Collaborations
Cevallos has collaborated with esteemed colleagues such as Honorine Ward and David Hamer. These partnerships have enhanced the scope and impact of his research.
Conclusion
Ana Maria Cevallos is a pioneering inventor whose work in host-parasite interactions has the potential to advance medical diagnostics and therapies. His contributions are valuable to the scientific community and hold promise for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile